Sleep Pharmaceuticals Jazz Pharmaceuticals Presents Latest Advancements at World Sleep 2023 October 18, 2023 RTSleepWorld Read Article
Sleep Pharmaceuticals Promising Results for Narcolepsy Type 1 Treatment, but Safety Concerns Arise July 28, 2023 RTSleepWorld Read Article
Sleep Lab Magazine Sleep Lab Magazine SLEEP 2023 Conference Edition June 1, 2023 RTSleepWorld Read Article
Sleep Pharmaceuticals Avadel Pharmaceuticals Receives FDA Approval of Bedtime Narcolepsy Treatment May 2, 2023 RTSleepWorld Read Article
News Emmanuel Mignot Wins Breakthrough Prize for Discovering Cause of Narcolepsy September 29, 2022 RTSleepWorld Read Article
Study Jazz Pharmaceuticals Presents 18 Abstracts at SLEEP 2021 June 11, 2021 RTSleepWorld Read Article
Pharmaceuticals Jazz Gets FDA Approval of Xywav for Narcolepsy Related Cataplexy or EDS July 23, 2020 RTSleepWorld Read Article
Pharmaceuticals First Non-Scheduled Narcolepsy Treatment Coming Soon August 16, 2019 RTSleepWorld Read Article